Pamela Palmer, MD, PhD, envisioned a different way to treat moderate-to-severe acute pain. Learn what inspired the AcelRx cofounder to develop a novel noninvasive technology.Read the story »
If your hospital is facing an IV opioid shortage during the COVID-19 pandemic, AcelRx may be able to provide assistance. Please read the letter from Dr. Palmer to learn more about this option.Read the letter »
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.
DSUVIA® was developed using this proprietary sublingual technology.